Evommune, Inc. (EVMN) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $205.57M | +242.5% |
| 2024 | -$144.24M | -85.6% |
| 2023 | -$77.71M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $205.57M | +242.5% |
| 2024 | -$144.24M | -85.6% |
| 2023 | -$77.71M | — |